CHICAGO--(BUSINESS WIRE)-- Meitheal Pharmaceuticals (“Meitheal”), a fully integrated generic injectables company based in Chicago, is proud to be “Certified” by Great Place to Work® for the first time. Meitheal was also recently named as one of the 2022 Best Places to Work in Illinois, presented by The Daily Herald Suburban Business.
“We are thrilled to become Great Place to Work-Certified™ and to be named one of the Best Places to Work in Illinois as we consider employee experience a top priority every day,” said CEO Tom Shea. “We owe our continued success to our team of dedicated employees at Meitheal. We celebrate and thank them for all they do to earn this incredible recognition.”
Great Place to Work® is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation. Great Place to Work® is a prestigious award based entirely on what current employees say about their experience working at Meitheal.
“Great Place to Work Certification™ isn’t something that comes easily – it takes ongoing dedication to the employee experience,” said Sarah Lewis-Kulin, vice president of global recognition at Great Place to Work. “It’s the only official recognition determined by employees’ real-time reports of their company culture. Earning this designation means that Meitheal is one of the best companies to work for in the country.”
When asked about their experiences, employees at Meitheal emphasized the company’s collaborative and flexible culture as well as open communication and supportive leadership as contributing to making it a great workplace.
According to Great Place to Work® research, job seekers are 4.5 times more likely to find a great boss at a Certified workplace. Additionally, employees at Certified workplaces are 93% more likely to look forward to coming to work, and are twice as likely to be paid fairly, earn a fair share of the company’s profits, and have a fair chance at promotion.
Meitheal was also recognized and honored as one of the best places of employment in Illinois, benefiting the area’s economy, workforce and businesses in the Best Places to Work in Illinois 2022.
“We strive every day to be a valued partner to our employees and communities in Chicago and Illinois,” said Shea. “Over the past five years we’ve worked hard to create a company culture that lives up to our values of working together for a common good. These awards are recognition of these efforts as we continue to attract top talent for our growing business.”
WE’RE HIRING!
Looking to grow your career at a company that puts its people first? Visit our careers page at: www.meithealpharma.com.
Meitheal primarily specializes in the development, manufacture, procurement, and sale of generic injectable pharmaceuticals, with 51 FDA-approved products (directly or through third party partners) covering indications for anti-infective, oncolytic, and intensive care. Furthermore, Meitheal has an expanding product portfolio and robust pipeline, including single and multi-dose vials, ready-to-use prefilled syringes and premixed bags. As of the end of June 2022, Meitheal, directly or through its partners, had 23 products in the research and development phase, 22 products were under review by the US Food and Drug Administration (FDA), and 14 products were planned to be launched in 2022.
ABOUT MEITHEAL PHARMACEUTICALS
Since 2017, Meitheal Pharmaceuticals has bridged critical gaps in the US healthcare market by supplying high quality, affordable generic injectables. Our diversified product range — from antibiotics, anticoagulants, and muscle relaxants to drugs used in chemotherapy — represents practical solutions for countless patients around the country, as well as Meitheal’s commitment to their care. Based in Chicago, Illinois, our aim each day is producing quality and ensuring affordability, using the traditional Irish guiding principle we are named for — Meitheal (Mee·hall): working together toward a common goal, for the greater good.
Learn more about who we are and what we do at www.meithealpharma.com.
ABOUT GREAT PLACE TO WORK CERTIFICATION™
Great Place to Work Certification™ is the most definitive “employer-of-choice” recognition that companies aspire to achieve. It is the only recognition based entirely on what employees report about their workplace experience – specifically, how consistently they experience a high-trust workplace. Great Place to Work Certification is recognized worldwide by employees and employers alike and is the global benchmark for identifying and recognizing outstanding employee experience. Every year, more than 10,000 companies across 60 countries apply to get Great Place to Work-Certified.
ABOUT GREAT PLACE TO WORK®
Great Place to Work® is the global authority on workplace culture. Since 1992, they have surveyed more than 100 million employees worldwide and used those deep insights to define what makes a great workplace: trust. Their employee survey platform empowers leaders with the feedback, real-time reporting and insights they need to make data-driven people decisions. Everything they do is driven by the mission to build a better world by helping every organization become a great place to work For All™.
Learn more here.
ABOUT BEST PLACES TO WORK IN ILLINOIS
The Best Places to Work in Illinois is a survey competition to determine which participants are the state’s best employers. The process is managed by Best Companies Group (BCG), an independent research firm specializing in identifying and recognizing great places to work. BCG manages programs worldwide, including in the US, UK, and Canada.
Learn more here
MEDIA CONTACT
Meitheal Pharmaceuticals, Inc.
John Spilman, VP of Corporate Strategy
773 889 5910
